Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
16
Number of overlapping holdings
30.8%
% of BBP's 55 holdings also in PBE
57.1%
% of PBE's 28 holdings also in BBP
Overlap by Weight
Sector Drift (BBP minus PBE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBP |
Weight in PBE |
Overlap | |
|---|---|---|---|---|
 |
PTC THERAPEUTICS INC | 2.1% | 2.9% | 2.1% |
|
BLUEPRINT MEDICINES CORP. | 2.0% | 2.8% | 2.0% |
|
REGENERON PHARMACEUTICALS | 2.0% | 5.1% | 2.0% |
|
INTRA-CELLULAR THERAPIES INC | 2.0% | 2.6% | 2.0% |
|
NEUROCRINE BIOSCIENCES INC | 1.9% | 5.3% | 1.9% |
Position Highlights (Non-Overlapping Exposures)
BBP Overweight Relative to PBE
|
TARSUS PHARMACEUTICALS, INC. | 3.5% |
|
LEXICON PHARMACEUTICALS, INC. | 3.4% |
|
SPRINGWORKS THERAPEUTICS, INC. | 2.6% |
|
AGIOS PHARMACEUTICALS INC | 2.5% |
|
ADMA BIOLOGICS, INC. | 2.5% |
|
SAREPTA THERAPEUTICS INC | 2.4% |
|
CRISPR THERAPEUTICS AG | 2.4% |
|
KINIKSA PHARMACEUTICALS LTD. CLASS A | 2.3% |
|
ASCENDIS PHARMA A/S | 2.3% |
|
AMYLYX PHARMACEUTICALS, INC. | 2.3% |
BBP Underweight Relative to PBE
|
BIO-TECHNE CORPORATION | -4.8% |
|
COLLEGIUM PHARMACEUTICAL, INC. | -3.5% |
|
NEUROCRINE BIOSCIENCES INC | -3.4% |
|
BIOMARIN PHARMACEUTICAL INC | -3.4% |
|
GILEAD SCIENCES INC | -3.3% |
|
BIOGEN IDEC INC | -3.2% |
|
CATALYST PHARMACEUTICAL PART | -3.1% |
|
REGENERON PHARMACEUTICALS | -3.1% |
|
TG THERAPEUTICS INC | -3.0% |
|
AMGEN INC | -3.0% |